Literature DB >> 21554176

Therapeutic plasticity of stem cells and allograft tolerance.

Valeria Sordi1, Lorenzo Piemonti.   

Abstract

Transplantation is the treatment of choice for many diseases that result in organ failure, but its success is limited by organ rejection. Stem cell therapy has emerged in the last years as a promising strategy for the induction of tolerance after organ transplantation. Here we discuss the ability of different stem cell types, in particular mesenchymal stromal cells, neuronal stem/progenitor cells, hematopoietic stem cells and embryonic stem cells, to modulate the immune response and induce peripheral or central tolerance. These stem cells have been studied to explore tolerance induction to several transplanted organs, such as heart, liver and kidney. Different strategies, including approaches to generating tolerance in islet transplantation, are discussed here.

Entities:  

Mesh:

Year:  2011        PMID: 21554176     DOI: 10.3109/14653249.2011.583476

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  17 in total

1.  Stroke therapy: the potential of amniotic fluid-derived stem cells.

Authors:  Maya Elias; Jaclyn Hoover; Hung Nguyen; Stephanny Reyes; Christopher Lawton; Cesar V Borlongan
Journal:  Future Neurol       Date:  2015

Review 2.  Immunomodulation in stem cell differentiation into neurons and brain repair.

Authors:  Henning Ulrich; Isis Cristina do Nascimento; Jozsef Bocsi; Attila Tárnok
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

Review 3.  Mesenchymal stem cell therapy for osteoarthritis.

Authors:  Hassan Afizah; James Hoi Po Hui
Journal:  J Clin Orthop Trauma       Date:  2016-06-22

4.  Bone marrow-derived mesenchymal stem cells inhibits hepatocyte apoptosis after acute liver injury.

Authors:  Yijing Cai; Zhuolin Zou; Liyuan Liu; Si Chen; Yi Chen; Zhuo Lin; Keqing Shi; Lanman Xu; Yongping Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Role of Human Wharton's Jelly Derived Mesenchymal Stem Cells (WJ-MSCs) for Rescue of d-Galactosamine Induced Acute Liver Injury in Mice.

Authors:  Raghu Ramanathan; Secunda Rupert; Sakthivel Selvaraj; Jeswanth Satyanesan; Rosy Vennila; Surendran Rajagopal
Journal:  J Clin Exp Hepatol       Date:  2017-04-01

6.  Mesenchymal stem cell transfusion for desensitization of positive lymphocyte cross-match before kidney transplantation: outcome of 3 cases.

Authors:  G Saadi; F Fadel; M El Ansary; S Abd El-Hamid
Journal:  Cell Prolif       Date:  2013-04       Impact factor: 6.831

7.  Strategy for the creation of clinical grade hESC line banks that HLA-match a target population.

Authors:  Laureen Jacquet; Emma Stephenson; Robert Collins; Heema Patel; Jane Trussler; Roaa Al-Bedaery; Pamela Renwick; Caroline Ogilvie; Robert Vaughan; Dusko Ilic
Journal:  EMBO Mol Med       Date:  2012-11-19       Impact factor: 12.137

Review 8.  Therapeutic implications of mesenchymal stem cells in liver injury.

Authors:  Maria Ausiliatrice Puglisi; Valentina Tesori; Wanda Lattanzi; Anna Chiara Piscaglia; Giovanni Battista Gasbarrini; Domenico M D'Ugo; Antonio Gasbarrini
Journal:  J Biomed Biotechnol       Date:  2011-12-20

Review 9.  The effects of TLR activation on T-cell development and differentiation.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Ying-Xiang Yang; Anthony E T Yeo
Journal:  Clin Dev Immunol       Date:  2012-06-07

Review 10.  The immune response of stem cells in subretinal transplantation.

Authors:  Bikun Xian; Bing Huang
Journal:  Stem Cell Res Ther       Date:  2015-09-14       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.